🇺🇸

US SEC Filing Intelligence

· daily

General Federal Contracts — May 05, 2026

The single contract analyzed totals $242,713,808 in obligations to FCN, INC. from the Department of the Treasury's IRS, representing a 100% civilian award with no defense exposure. Dominant theme is IRS IT Strategy and Modernization, highlighted by FCN's full and open competition win for Broadcom software licenses and maintenance under a firm fixed price delivery order. Highest-conviction bullish signal is FCN's strong execution with $240,260,396 already outlayed on the $242M obligation, signaling rapid progress toward the November 30, 2026 current end date. Key watch item is option exercises that could expand to $454,642,987 total potential, alongside high pricing risk inherent in the firm fixed price structure.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 05, 2026

Across 28 filings in the S&P 500 Technology stream, core tech names like AMD, Arista Networks, CrowdStrike, Klaviyo, and Salesforce showcase explosive revenue growth averaging 28% YoY (AMD +38%, Arista +35%, Klaviyo +28%, CrowdStrike +22%), fueled by AI/data center (AMD DC +57% to $5.8B) and software expansion (CrowdStrike ARR +24% to $5.25B), with institutional 13Fs from Varma, Factory Mutual, and Illinois MRF confirming mega-cap conviction (NVDA/AAPL tops). Guidance trends bullish with raises at AMD (Q2 rev +46% YoY to $11.2B), Arista (Q2 $2.8B), Klaviyo (FY26 $1.51-1.52B +23-24%), offset by mixed margins (Arista GAAP gross -180bps YoY) and cash flow variability. Capital allocation favors buybacks (Salesforce $50B auth, Klaviyo $500M) over dividends in tech, while non-tech filings (banks/REITs) flag provision surges and debt rises. Portfolio-level: Tech outliers outperform with AI catalysts, but watch leadership churn (Klaviyo CFO exit) and QoQ flats. Implications: Overweight AI enablers; sector growth accelerates amid institutional flows.

12 high priority 16 medium 28 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 05, 2026

Across 25 filings from NASDAQ-100 related entities, Q1 2026 results reveal broad revenue growth averaging ~20% YoY in reporting companies (e.g., AMD +38%, Entravision +114%, Weave +17%), but persistent margin compression (PayPal -182bps operating margin, SBA net income -16%) and rising provisions/expenses signal cost pressures amid economic uncertainty. Tech and institutional 13F filings (Varma, Amazon, Sharpepoint, Factory Mutual, Illinois MRF) confirm heavy overweight to NVIDIA, Apple, Alphabet, Microsoft, underscoring sector conviction despite no changes reported. Capital allocation remains shareholder-friendly with buybacks (PayPal $1.5B), dividend increases (Amalgamated +21% to $0.17, Entravision $0.05), and REIT acquisitions (CHCT $28.5M at 9.3% return). Guidance trends positive with raises (Mueller EBITDA to $360-365M, AMD Q2 rev $11.2B +46% YoY) offsetting PayPal's reiterated low-single digit EPS outlook. M&A/partnership activity (Inmune Bio expansion, Richmond merger reminder) and neutral events (auditor changes, bond issuances) add limited alpha, while bio/healthcare shows divergence (INMB positive vs Mustang Bio loss widening). Portfolio implication: Favor semis/ad-tech outperformers; monitor REIT debt rises and bank provisions for downside risks.

11 high priority 14 medium 25 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 05, 2026

Across 50 SEC filings dated May 5, 2026, primarily Q1 2026 earnings and corporate actions, mixed sentiment dominates (65% of filings), with revenue growth averaging +10% YoY in 25 reporters (e.g., Ecovyst +50%, Terex +41%, Paymentus +30%) offset by margin compressions in 15 cases (avg -200bps, e.g., Atkore -780bps) due to costs, impairments, and one-offs. Financials subset (e.g., bank 0000083246 NI +45% YoY, Oaktree BDC income -9% QoQ) shows improving credit provisions (-59% YoY) but deposit/loan pressures. Capital allocation prioritizes returns: $1.8B+ in buybacks/ASRs (Gartner $535M +$600M auth, DuPont $275M, Five9 $90M, Ecovyst $35.7M) and dividends (e.g., Atkore $0.33, Fresh Del Monte $0.30). M&A/divestitures active for focus/delevering (Compass $280M proceeds targeting <1.0x leverage, Helix $107.5M sale, Expro $215M acq). Guidance raised in 8/15 cases (DuPont EPS $2.35-2.40, ADM $4.15-4.70, Ecovyst EBITDA $180-195M), signaling resilience amid macro challenges. SPAC IPOs (CH4 $200M, ARC $105M) highlight M&A appetite. Portfolio implication: Favor capital returners with raised guidance; monitor margin trends and merger closes.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 05, 2026

Across 50 filings from diverse sectors (with Consumer Staples highlights in ADM, Fresh Del Monte, BellRing), results show mixed Q1/FY2026 performance: 65% reported revenue growth averaging +6% YoY (e.g., DuPont +4%, Exelixis +10%, Rockwell +12%), but 55% faced margin compression (avg -200bps, e.g., Atkore -780bps, BellRing gross -530bps) amid input costs, impairments, and one-offs. Capital allocation remains robust with $2B+ in buybacks/dividends (Emerson $2.2B FY, DuPont $275M ASR, KKR $317M), signaling shareholder focus despite $1B+ debt increases in some (Fresh Del Monte +$265M). Guidance raised in 30% (ADM EPS to $4.15-4.70, DuPont sales $7.155-7.215B), lowered in others (QuidelOrtho rev $2.70-2.75B); divestitures unlocked $2.5B+ value (DuPont Aramids $1.2B, Helix $107.5M). Consumer Staples theme: ADM outperforms with +48% Carbohydrate Solutions profit, but Fresh Del Monte -4.9% sales and BellRing volume gains offset by pricing declines signal volume vs. pricing tension. Portfolio trend: Industrials/mats resilient (Emerson margin +320bps), REITs/mortgages pressured (Granite Point net loss improved but portfolio -175M). Implications: Favor guidance-raisers with buybacks for near-term alpha; monitor margin trends and catalysts like Exelixis PDUFA Dec 2026.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 05, 2026

Across 50 SEC filings from S&P 500 Industrials and related sectors for Q1 2026, mixed sentiment prevails in 70% of reports, driven by robust revenue growth in 25 companies (avg +12% YoY, e.g., Eaton +17%, IDEXX +14%) offset by margin pressures (avg -80 bps in 15 firms) and segment declines. Acquisitions dominate capital allocation with $25B+ deployed (Eaton $11B, Waters BD unit), boosting assets but spiking debt (Eaton LT debt +112% to $18.5B). Guidance raised in 12 firms (e.g., Eaton organic 9-11%, Waters rev $6.4-6.45B), signaling conviction amid Aerospace/Electrical strength (+16-21% YoY). Dividend hikes (Sunoco +6.25%, Ferguson $0.89) and buybacks (Dave 7% shares, DuPont $275M ASR) highlight shareholder returns totaling $3B+. Insider patterns limited, but proxy votes (Lattice 95-98% director approval) show alignment; M&A catalysts cluster in Q2-Q3. Portfolio trend: Industrials outpace REITs/pharma with 8/10 revenue beaters, but watch debt leverage (avg 3.5x up 20% YoY in acquirers). Actionable: Favor electrical/aerospace growers, trim high-debt REITs pre-mergers.

9 high priority 41 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 05, 2026

S&P 500 Energy sector filings highlight robust upstream production growth and consolidation via Devon Energy's shareholder-approved merger with Coterra (close ~May 7, 2026, $1B synergies by 2027), alongside mixed Q1 2026 results: EOG Resources led with +27% YoY total production to 1,384 MBoed, +22% revenues to $6.9B, and +30% CFO to $3.0B, while Marathon Petroleum swung to $511M net income (+$585M YoY) on refining margins +$4.36/bbl to $17.74 but midstream EBITDA -7% to $1.6B. Occidental Petroleum showed one-time gains from OxyChem sale boosting net income to $3.2B but continuing ops income -72% YoY to $236M and sales -8% amid debt reduction to $13.3B toward $10B target. Capital returns remain strong with MPC's new $5B buyback, EOG dividends +5% to $1.02/share, and Devon FCF $816M; however, cost pressures (EOG op ex +13%, MPC refining costs +8%) signal margin risks. Neutral 13F filings from Williams Jones and Duncan Williams show no major energy shifts, while non-core filings (CommScope M&A, Real Brokerage merger comms) add minimal sector alpha. Portfolio-level: 4/4 key energy cos reported production beats or guidance tops, but refining/midstream mixed, pointing to upstream outperformance amid consolidation.

5 high priority 8 medium 13 total filings
· daily

US Material Events SEC 8-K Filings — May 05, 2026

Across 50 SEC filings from May 5, 2026, dominant themes include a surge in SPAC IPOs and merger announcements (9 filings, e.g., CH4, ARC, DMAA), robust insurance sector growth (Bowhead premiums +24% YoY, combined ratio improved to 95.3%), mixed Q1/FY2026 earnings with average revenue growth of ~12% YoY in reporting companies but varied margins (e.g., expansions in InTest +400bps, compressions in some like BrightView net income -73%), and frequent leadership transitions (14 filings, mostly neutral/positive). M&A, divestitures, and financing extensions signal portfolio optimization and liquidity bolstering (e.g., Compass sale $280M proceeds, Helix $107.5M divestiture). Period-over-period trends show 18/22 earnings reporters with YoY revenue growth (avg +13%), but 9 with EBITDA/net income declines amid investments; forward guidance largely raised or reaffirmed (12 instances), pointing to underlying resilience. Capital allocation favors returns (Emerson $2.2B, Klaviyo $500M buyback) over aggressive growth capex. Sector patterns highlight SPAC dry powder influx (~$465M IPOs priced), deleveraging in diversified holdings, and AI/tech momentum (DigitalOcean ARR +22%). Market implications: Bullish for SPACs/insurance, cautious on consumer/industrials amid weather/Macro headwinds, with near-term catalysts from closings and earnings.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 05, 2026

Across the 50 pre-analyzed SEC filings from the USA Dow Jones 30 intelligence stream (primarily Q1 FY26 results), mixed sentiment dominates (24/50 filings), with revenue growth averaging +12% YoY in reporting companies (e.g., Entravision +114%, Ecovyst +50%, DigitalOcean +22%) but frequent net income declines or margin pressures (e.g., 8/15 Q1 reporters saw NI drops averaging -40% YoY amid higher opex/capex). Capital allocation remains robust, with 12 companies announcing buybacks/repurchases totaling >$1.5B (e.g., Five9 $90M ASR, Leidos $243M Q1), dividends (e.g., Atkore $0.33/share, Central Ban $0.12/share), and deleveraging via asset sales/M&A (e.g., Compass $280M proceeds, Expro $215M acquisition). Guidance was raised or reaffirmed in 10+ cases (e.g., DigitalOcean to 26% growth, Ecovyst EBITDA to $180-195M), signaling management confidence despite headwinds like input costs, seasonality, and one-offs. M&A and leadership transitions (e.g., Integra new CEO, Devon merger approval closing May 7) highlight portfolio reshaping, while insider buying in Neonode (CEO +80k shares) contrasts dilution risks (AMC 142M new shares). Sector patterns show energy/tech outperformance in topline but profitability volatility, with banks/utilities stable. Implications: Tactical buys in guidance-raisers with buybacks; caution on margin squeezes and liquidity waivers.

19 high priority 31 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 05, 2026

Across 50 SEC filings for May 5, 2026, Q1 2026 earnings dominate with mixed sentiment prevailing in 70% of reports, featuring revenue growth in 12 companies (avg +15% YoY) offset by margin compression in 8 (avg -150 bps) amid input costs, FX, and one-offs. Industrials and chemicals shine with beats/raises (DuPont +15% EBITDA, Ecovyst +87%), while energy sees M&A catalysts like Coterra-Devon merger closing May 7. Capital allocation leans bullish with $2.5B+ in repurchases/dividends announced (Gartner $535M, Five9 $90M ASR), but biotech/fintech show losses widening (Eve +41% net loss, IDEAYA +18%). Divestitures (DuPont Aramids $1.2B, Compass Sterno $292.5M) signal portfolio optimization, and SPAC IPOs (CH4 $200M, ARC $105M) indicate deal appetite. Portfolio trend: 6/10 firms raised FY2026 guidance, signaling resilience; watch margin trends and energy consolidation for alpha.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 05, 2026

Across 50 SEC filings from the USA S&P 500 Consumer Discretionary intelligence stream (primarily retail, automotive, restaurants, hotels, entertainment), Q1 2026 earnings dominate with mixed sentiment: 70% of revenue-reporting companies showed YoY growth averaging +15% (e.g., Shopify +34%, Fabrinet +39%, Life Time Group +11.7%), but 40% faced margin compression averaging -120 bps amid cost pressures (e.g., TransDigm EBITDA margin -140 bps, Fiserv -890 bps). Capital allocation remains shareholder-friendly, with 18 companies announcing/expanding buybacks (total ~$7B incl. TransDigm $905M YTD, DFIN new $150M) and 12 dividend declarations/hikes (e.g., Energy Transfer +3% to $0.3375/unit). M&A/divestitures active in 8 filings (Ferguson 5+ deals, Compass $292.5M sale), supporting deleveraging and growth. Forward guidance largely affirmed/raised (e.g., Energy Transfer EBITDA to $18.2-18.6B, Shopify Q2 high-20s% growth), signaling management conviction despite macro headwinds. Consumer Discretionary outliers shine with resilient demand (First Watch +17% rev, Haverty comp sales +4.3%), positioning for outperformance vs. broader mixed trends. Portfolio implication: overweight growth leaders with strong capital returns; monitor margin trends and Q2 catalysts.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 05, 2026

Across 50 filings in the USA S&P 500 Healthcare intelligence stream (though including cross-sector disclosures), dominant themes include mixed financial results in biotechs and medtech with YoY loss narrowing via cost cuts (e.g., Editas -67%, Precision Bio rev +>100x), revenue growth in diagnostics/pharma (IDEXX +14% YoY, Pfizer non-COVID +7%), and leadership transitions (Integra CEO change). Period-over-period trends show 7/12 key healthcare firms with organic revenue growth averaging +6% YoY but margin volatility (e.g., Integra gross +460bps, BrightView net income -73%); financials/funds exhibit NII growth offset by higher provisions (Amalgamated +13.5% NII but prov +>20x). Forward-looking catalysts cluster in H1-H2 2026 (FDA PDUs, trials, AGMs), with capital returns via buybacks (BrightView 1.1M shares, DFIN $28M) signaling confidence amid cash burn. Portfolio-level patterns reveal biotech efficiency gains (R&D cuts 20-34% YoY) contrasting energy funds' revenue declines (avg -30% YoY), implying healthcare resilience vs cyclical weakness. Critical implications: Biotech turnarounds offer alpha; monitor proxy fights (Pacira June 9) and guidance reaffirms (Pfizer FY $59.5-62.5B).

18 high priority 32 medium 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 05, 2026

Across 12 DEF 14A proxy filings dated around May 5, 2026, overarching themes include routine annual meetings for director elections (9/12), auditor ratifications (10/12), say-on-pay advisory votes (5/12), and equity incentive plan approvals, alongside special actions like share increases (Orgenesis, FibroBiologics), SPAC deadline extensions (Range Capital), reverse stock splits (Beyond Air), and reincorporations (Sonoma). Key period-over-period trends: CrowdStrike's FY2026 revenue +22% YoY to $4.81B, ARR +24% YoY to $5.25B, FCF margin 26%; FONAR exec comp down 21% YoY for CEO to $295k while flat for another; Range Capital trust +5.6% to $121.9M from post-IPO $115.6M. Critical developments: delisting risks (Beyond Air), dilution proposals (4/12 filings), and strong governance signals (Workday). Market implications: heightened dilution risks in biotechs/SPACs signal bearish near-term pressure, while SaaS leaders like CrowdStrike show portfolio-level growth outperformance; neutral sentiment dominates (8/12), but vote outcomes could drive volatility ahead of summer meetings.

12 high priority 12 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 05, 2026

Two S-4 filings on May 05, 2026, underscore active merger-driven paths in the US IPO pipeline, with ATII Holdings advancing a SPAC business combination between Forge Nano Inc. and Archimedes Tech SPAC Partners II Co., while Mountain Holding (New Equitable) pursues consolidation of Corebridge Financial ($385B AUM) and Equitable Holdings (>$1.1T AUM) into a new NYSE-listed EQH entity. Period-over-period data reveals stable customer concentration at ATII (two major revenue customers in 2025 vs. two in 2024), indicating revenue reliability but no broader growth metrics available across filings. Critical developments include ATII's lock-up expiration today (2026-05-05) for sponsors, insiders, and Forge Nano holders, and Mountain's targeted merger close by year-end 2026 pending multi-regulator approvals. Neutral sentiment at ATII contrasts with mixed at Mountain due to execution risks detailed from page 44. Portfolio-level patterns highlight merger/SPAC reliance for public access, with scale in financials (> $1.485T combined AUM) but regulatory hurdles prevalent. Market implications favor monitoring unlock volatility and approval catalysts for near-term trading alpha.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — May 05, 2026

Across 50 filings in the Global High Priority Market Events stream (US SEC focus), dominant themes include robust revenue and PAT growth in automotive/manufacturing (e.g., Mahindra & Mahindra +25% FY26 revenue YoY), margin expansions amid volume challenges in consumer goods (Energizer +360 bps gross margin), and SPAC IPO momentum (ARC Group $105M, CH4 $200M) signaling M&A appetite in tech/healthcare/logistics and nature-based assets. Period-over-period trends show average revenue growth of ~15-25% YoY in 12/20 detailed quarterly reporters (e.g., DigitalOcean +22%, Duolingo +27%), but net income volatility with 6/15 mixed/negative due to one-offs (Grayscale -51% NAV QoQ, BrightView net income -73% YoY). Crypto assets tanked (GDLC unrealized losses $463M), while mergers like Equitable/Corebridge advance with $500M+ synergies targeted YE2026. Capital allocation leans shareholder-friendly: dividend hikes (Mahindra +30% to ₹33/share), buybacks (Gartner $535M, BrightView 1.1M shares), but risks cluster in Indian insolvencies/defaults (Dharani Sugars 57Cr principal default, Bihar Sponge IBC notice). Guidance largely raised (InTest FY26 rev $130-135M, DigitalOcean +26% FY26), building Q2-H2 2026 catalysts; portfolio-level: outperformance in non-cyclical tech/auto vs. underperformance in utilities/crypto.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 05, 2026

Across 50 Q1 2026 10-Q filings, sentiment is overwhelmingly mixed (46/50), with revenue growth in 35/50 companies averaging +18% YoY (outliers like Fabrinet +39%, EVgo +45%, Paymentus +30%), but offset by net income declines or widened losses in 28/50 due to expense inflation (avg +20% YoY in SG&A/R&D) and higher interest/provisions. Cash flows show volatility: operating cash up YoY in 22/50 (e.g., Duolingo +43%, Gartner +25%), but down or negative in 18/50 amid inventory/receivable builds. Capital allocation leans shareholder-friendly with buybacks in 12 companies (e.g., Gartner $535M, TopBuild via share reduction) and dividend hikes (e.g., Amalgamated +21%, Tompkins +8%), while debt reductions signal deleveraging in 10 firms. Financials exhibit NII growth (+10% avg) but rising provisions; tech/energy mixed with volume gains but derivative/opex hits. Portfolio implication: Favor high-growth outliers like Duolingo/Shopify for momentum, monitor cash burn in biotechs/loss-makers; sector rotation toward profitable industrials (AGCO, Fabrinet). No major insider patterns noted, but buyback aggression flags conviction in mature names.

50 high priority 50 total filings
· daily

US SEC Trading Suspension Halt Orders — May 05, 2026

Four Nasdaq-listed micro-cap companies—PLAYSTUDIOS (MYPS), VenHub Global (VHUB), Envirotech Vehicles (EVTV), and Versus Systems (VS)—face imminent delisting risks due to failures in meeting minimum bid price ($1.00) or stockholders' equity ($2.5M) requirements under Nasdaq rules, with notices issued in late April 2026. Common themes include prolonged sub-$1 bid prices for 30 consecutive days (PLAYSTUDIOS, VHUB) and equity deficits below $2.5M as of Dec 31, 2025 (EVTV, VS at $1.92M), signaling deteriorating financial health amid no reported YoY/QoQ revenue growth or margin expansions in enriched data. PLAYSTUDIOS secured a transfer to Nasdaq Capital Market on May 6 with a second 180-day window to Nov 2; VHUB has initial 180 days to Oct 27; EVTV and VS must submit compliance plans by June 13, potentially extending to Oct 26. Versus shows relative resilience with a mixed sentiment from a $1.7M equity infusion at 105% premium, while others remain negative. No insider buying detected across filings, underscoring low management conviction; portfolio-level pattern reveals 100% negative/mixed sentiment and high delisting materiality (9/10), urging avoidance of long exposure in Nasdaq small caps. Forward-looking plans like reverse splits offer potential catalysts but carry no compliance guarantees.

4 high priority 4 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 05, 2026

Across 48 filings in the USA Corporate Distress & Bankruptcy stream (38 new), distress signals cluster in micro-cap Nasdaq/NYSE compliance failures (7 companies citing bid price < $1 or equity < $2.5M), plant closures, and widening losses (e.g., Rayonier sales -10% YoY, net loss doubled), but are overshadowed by 20+ positive catalysts including M&A/divestitures (12 deals totaling $2B+ value), debt refinancings/extensions (8 instances extending maturities 3-5 years), equity offerings ($500M+ raised), and guidance raises (INTEST FY rev to $130-135M, DigitalOcean FY26 +26%, ONITY ROE 10-15%). Period trends show revenue growth averaging +18% YoY in reporting firms (e.g., INTEST +27%, Bowhead premiums +24%, DigitalOcean +22%), margin expansions in 6/15 cases (INTEST +400bps gross), but compressions/declines in others (BrightView Development EBITDA -44%, Rayonier op loss widened); no insider trades reported, capital allocation favors growth/reinvestment over buybacks/dividends. Portfolio-level: Small-cap distress creates short opportunities, while mid-caps pursue consolidation/deleveraging for resilience. Implications: Monitor delisting risks for downside, pivot to M&A plays for alpha amid improving liquidity.

48 high priority 48 total filings
· daily

US Executive Officer Management Changes SEC — May 05, 2026

Across 36 filings in the USA Executive & Director Changes stream, a dominant theme is high executive turnover, particularly in finance roles (CFOs, controllers, accounting officers in 12 companies including Atlantic American, Kimberly-Clark, Core Scientific, CF Industries, Genesco, Portillo's), with 18 appointments and 14 departures, often neutral but featuring experienced hires signaling continuity. Embedded Q1/FY2026 earnings show mixed revenue trends (avg +3.5% YoY across 15 reporting firms, but declines in 7 like Energizer -3%, FTC Solar -17%, Primoris -5.4%), offset by margin expansions (e.g., Energizer +360bps, Emerson +320bps) and reaffirmed/raised guidance in 10 cases. Positive sentiments dominate leadership adds (e.g., Integra, iAnthus, CF Industries), while negatives cluster around disputes (B&G Foods). Portfolio-level: Margin resilience amid soft volumes; capital returns strong ($500M Klaviyo buyback, $2.2B Emerson). Implications: Opportunities in experienced leadership turnarounds, risks in finance churn; watch catalysts like earnings calls.

36 high priority 36 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 05, 2026

The 35 filings in the 'USA Board Room Changes' stream reveal a wave of 25+ executive and board transitions, including 12 CEO/CFO appointments/resignations and 10+ director elections/additions, often featuring experienced hires amid mixed Q1 FY2026 earnings with average reported revenue growth of +6% YoY (Klaviyo +28% outlier, FTC Solar -17% low-end) and gross margin expansions in 4/10 reporting firms (Energizer +360bps standout). Declines in volumes/sales hit cyclical sectors (Energizer batteries -6.1%, Primoris Energy -13.8%), but Adjusted EBITDA grew +10% on average where disclosed, driven by organic expansions and acquisitions. Guidance was raised/reaffirmed in 8/12 cases (e.g., AdaptHealth revenue to $3.45-3.52B, Klaviyo to $1.514-1.522B), signaling management confidence post-changes; capital returns strong via $500M+ buybacks (Klaviyo, Emerson). Positive sentiment in 40% of filings tied to continuity hires (Integra Essig return), while neutral/negative in departures without successors (Portillo CFO). Portfolio implications: Healthcare and industrials show leadership stabilization for growth, consumer CFO churn flags execution risks. Overall, transitions lean positive for long-term execution, with near-term catalysts from earnings calls.

35 high priority 35 total filings